CYP2D6 and Tamoxifen: Awaiting the Denouement Reply

被引：0
|
作者：
Rae, James M. [1 ]
机构：
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 34期
关键词：
PHARMACOGENETICS; METABOLITE;
D O I：
10.1200/JCO.2011.39.0971
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4590 / 4591
页数：3
相关论文
共 50 条
  • [1] CYP2D6 and Tamoxifen: Awaiting the Denouement
    Brauch, Hiltrud B.
    Schroth, Werner
    Ingle, James N.
    Goetz, Matthew P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (34) : 4589 - 4590
  • [2] Avoidance of CYP2D6 Inhibitors in Patients Receiving Tamoxifen Reply
    Dezentje, Vincent O.
    van Blijderveen, Nico J. C.
    Gelderblom, Hans
    Putter, Hein
    van Herk-Sukel, Myrthe P. P.
    Casparie, Mariel K.
    Egberts, Antoine C. G.
    Nortier, Johan W. R.
    Guchelaar, Henk-Jan
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : E586 - E586
  • [3] CYP2D6 genotype and tamoxifen response
    James M Rae
    Matthew P Goetz
    Daniel F Hayes
    James N Ingle
    Lang Li
    Anna Maria Storniolo
    Vered Stearns
    David A Flockhart
    Breast Cancer Research, 7
  • [4] Tamoxifen and CYP2D6: A Contradiction of Data
    Hertz, Daniel L.
    McLeod, Howard L.
    Irvin, Dwilliam J., Jr.
    ONCOLOGIST, 2012, 17 (05): : 620 - 630
  • [5] CYP2D6 Genotype and Adjuvant Tamoxifen
    Berry, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (02) : 138 - 140
  • [6] CYP2D6 genotype and tamoxifen response
    Rae, JM
    Goetz, MP
    Hayes, DF
    Ingle, JN
    Li, L
    Storniolo, AM
    Stearns, V
    Flockhart, DA
    BREAST CANCER RESEARCH, 2005, 7 (05)
  • [7] The effect of CYP 2D6 genotype and CYP2D6 inhibitors on tamoxifen
    Stearns, V
    Hayes, DF
    Jin, Y
    Ullmer, L
    Nguyen, A
    Storniolo, AM
    Flockhart, U
    Desta, Z
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 5S - 5S
  • [8] CYP2D6 polymorphisms associated with tamoxifen outcome
    Hutchinson L.
    Nature Reviews Clinical Oncology, 2009, 6 (12) : 675 - 675
  • [9] CYP2D6 Polymorphisms and the impact on tamoxifen therapy
    Beverage, Jacob N.
    Sissung, Tristan M.
    Sion, Amy M.
    Danesi, Romano
    Figg, William D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (09) : 2224 - 2231
  • [10] Coprescription of Tamoxifen and Medications That Inhibit CYP2D6
    Sideras, Kostandinos
    Ingle, James N.
    Ames, Matthew M.
    Loprinzi, Charles L.
    Mrazek, David P.
    Black, John L.
    Weinshilboum, Richard M.
    Hawse, John R.
    Spelsberg, Thomas C.
    Goetz, Matthew P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2768 - 2776
12345